Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-03-006477
Filing Date
2003-04-15
Accepted
2003-04-15 12:54:40
Documents
13
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 10-K j9385_10k.htm 10-K 1535267
3 EX-10.12 j9385_ex10d12.htm EX-10.12 40522
4 EX-10.13 j9385_ex10d13.htm EX-10.13 98980
5 EX-10.17 j9385_ex10d17.htm EX-10.17 20249
6 EX-10.19 j9385_ex10d19.htm EX-10.19 47805
7 EX-10.26 j9385_ex10d26.htm EX-10.26 12167
8 EX-10.37 j9385_ex10d37.htm EX-10.37 12732
9 EX-21.1 j9385_ex21d1.htm EX-21.1 3456
10 EX-23.1 j9385_ex23d1.htm EX-23.1 3127
11 EX-23.2 j9385_ex23d2.htm EX-23.2 5845
12 EX-99.1 j9385_ex99d1.htm EX-99.1 12916
13 EX-99.2 j9385_ex99d2.htm EX-99.2 10663
14 EX-99.3 j9385_ex99d3.htm EX-99.3 10440
  Complete submission text file 0001104659-03-006477.txt   1817099
Mailing Address 135 BEAVER ST WATHAM MA 02452
Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-0700
INTERLEUKIN GENETICS INC (Filer) CIK: 0001037649 (see all company filings)

EIN.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23413 | Film No.: 03650031
SIC: 2835 In Vitro & In Vivo Diagnostic Substances